Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SX3P
Consumer Staples
SX3P
Consumer Staples
SX3P
+0.95%
625.07
+5.86
+0.95%
—619.21618.96625.29615.58——
SX6P
Utilities
SX6P
Utilities
SX6P
+1.67%
539.74
+8.88
+1.67%
—530.86530.03539.70526.25——
SX8P
Technology
SX8P
Technology
SX8P
+0.49%
935.21
+4.59
+0.49%
—930.62924.86942.94921.75——
SXAP
Consumer Discretionary
SXAP
Consumer Discretionary
SXAP
-0.04%
455.88
-0.17
-0.04%
—456.05452.80456.62446.45——
SXDP
Health Care
SXDP
Health Care
SXDP
+0.10%
1,091.68
+1.05
+0.10%
—1,090.631,086.801,095.221,078.00——
SXEP
Energy
SXEP
Energy
SXEP
+1.40%
542.84
+7.50
+1.40%
—535.34536.16545.74536.16——
SXFP
Financials
SXFP
Financials
SXFP
+1.49%
903.48
+13.25
+1.49%
—890.23887.34904.15883.68——
SXKP
Communications
SXKP
Communications
SXKP
+1.54%
317.60
+4.82
+1.54%
—312.78311.95319.44310.80——
SXNP
Industrials
SXNP
Industrials
SXNP
+0.78%
1,104.18
+8.58
+0.78%
—1,095.601,090.801,109.451,082.31——
SXPP
Materials
SXPP
Materials
SXPP
-0.04%
817.73
-0.34
-0.04%
—818.07813.89826.30804.46——
300147:SHE
Xiangxue Pharmaceutical Co Ltd
CNÂ¥10.11
-5.16%
(-0.55) 1D
May 18, 3:04:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300147...
Open
CNÂ¥10.66
High
CNÂ¥10.75
Low
CNÂ¥9.98
Mkt. cap
7.05B
Avg. vol.
16.98M
Volume
15.77M
52-wk high
CNÂ¥12.79
52-wk low
CNÂ¥7.40
EPS
-CNÂ¥2.14
Shares outstanding
661.28M
No. of employees
3K
News stories
From sources across the web
Profile
Xiangxue Pharmaceutical Co., Ltd. also known as XPH, is a Chinese pharmaceutical company. It was headquartered in Guangzhou Economic and Technological Development Zone, Guangzhou, the capital of the Guangdong Province. The company started in a place that near to the tourist spot Luogang Xiangxue, thus called itself Xiangxue. Xiangxue Pharmaceutical was a constituent of SZSE 200 Index, but was removed in January 2017; it was inserted to SZSE 700 Index instead at the same time. SZSE 200, 300 and 700 Indexes are subsets of SZSE 1000 Index, the latter is a stock market index for the top 1,000 companies by free-float adjusted capitalization. In July 2017 Xiangxue was also removed from SZSE Component Index, an index for top 500 companies of the exchange. Wikipedia
About Xiangxue Pharmaceutical Co Ltd
CEO-
Employees2.66K
FoundedDec 29, 1997
Headquarters-
SectorPharmaceutical industry
Websitexphcn.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
396.99M
327.92M
449.49M
354.16M
Cost of goods sold
310.12M
176.35M
375.44M
228.49M
Cost of revenue
310.12M
176.35M
375.44M
228.49M
Research and development expenses
17.44M
15.40M
22.13M
10.74M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
116.81M
132.20M
75.98M
89.74M
Operating expense
136.85M
153.13M
96.02M
97.30M
Total operating expenses
446.96M
329.48M
471.45M
325.80M
Operating income
-49.98M
-1.56M
-21.96M
28.36M
Other non operating income
-2.20M
302.00K
-720.05M
-115.28M
EBT including unusual items
-138.23M
-118.29M
-1.00B
-89.20M
EBT excluding unusual items
-131.84M
-67.96M
-542.04M
-87.35M
Income tax expense
-640.89K
3.13M
30.08M
9.14M
Effective tax rate
0.46%
-2.65%
-3.00%
-10.25%
Other operating expenses
3.76M
3.55M
-37.47K
-3.18M
Net income
-146.14M
-128.03M
-1.03B
-111.44M
Net profit margin
-36.81%
-39.04%
-229.21%
-31.47%
Earnings per share
-
-
-
-
Interest and investment income
-
-
200.59M
-
Interest expense
-79.66M
-66.70M
-619.18K
-
Net interest expenses
-79.66M
-66.70M
199.97M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
7.84M
52.99M
25.60M
75.93M
Gain or loss from assets sale
-932.06K
932.06K
-8.92M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer